freedom has been researched along with amygdalin in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rosen, GM; Shorr, RI | 1 |
| Markle, GE; Petersen, JC | 1 |
| Young, P | 1 |
| Spivak, J | 1 |
| Cowan, DH; Mulder, JH | 1 |
| Scriven, T | 1 |
| Sagoff, M | 1 |
| Merriken, K; Overcast, TD | 1 |
| Baron, CH | 1 |
| Martin, DS | 1 |
| Clinite, BJ | 1 |
| Brandt, EK | 1 |
| Link, M | 1 |
| Block, RE | 1 |
| Olson, RE | 1 |
| Cassell, EJ | 1 |
| Cooper, RM | 1 |
20 other study(ies) available for freedom and amygdalin
| Article | Year |
|---|---|
Laetrile: end play around the FDA. A review of legal developments.
Topics: Amygdalin; Biomedical Research; Drug Evaluation, Preclinical; Federal Government; Freedom; Government Regulation; History, 19th Century; History, 20th Century; Human Rights; Humans; Jurisprudence; Legislation, Drug; Personal Autonomy; Pharmaceutical Preparations; United States; United States Food and Drug Administration | 1979 |
High court ducks two issues, leaving Laetrile unchecked.
Topics: Amygdalin; Freedom; Government Regulation; Humans; Judicial Role; Jurisprudence; Neoplasms; Personal Autonomy; Social Control, Formal; Supreme Court Decisions; Terminally Ill; United States Food and Drug Administration | 1979 |
Politics and science in the Laetrile controversy.
Topics: Amygdalin; Civil Rights; Evaluation Studies as Topic; Freedom; Humans; Neoplasms; Patient Care; Personal Autonomy; Pharmaceutical Preparations; Politics; Social Values | 1979 |
Suenram v. Society of Valley Hospital. 30 Dec 1977.
Topics: Amygdalin; Civil Rights; Freedom; Hospitals; Humans; Jurisprudence; Neoplasms; Organizational Policy; Patient Care; Personal Autonomy; Pharmaceutical Preparations; Terminally Ill | 1977 |
Laetrile: hope for cancer patients, or just a hoax?
Topics: Amygdalin; Civil Rights; Evaluation Studies as Topic; Freedom; Humans; Neoplasms; Patient Care; Personal Autonomy; Pharmaceutical Preparations | 1977 |
Laetrile's message to the FDA.
Topics: Amygdalin; Attitude; Authoritarianism; Federal Government; Freedom; Government; Government Regulation; Humans; Neoplasms; Personal Autonomy; Pharmaceutical Preparations; Physicians; Public Opinion; Public Policy; Social Control, Formal; United States Food and Drug Administration | 1977 |
The ethics of clinical trials of ineffective therapy.
Topics: Amygdalin; Complementary Therapies; Ethical Analysis; Ethics; Food; Freedom; Human Experimentation; Humans; Informed Consent; Jurisprudence; Neoplasms; Patient Care; Patient Selection; Personal Autonomy; Privacy; Research Design; Research Subjects | 1981 |
Utility, autonomy and drug regulation.
Topics: Amygdalin; Drug Industry; Ethical Theory; Ethics; Evaluation Studies as Topic; Federal Government; Freedom; Government; Government Regulation; Human Rights; Humans; Jurisprudence; Paternalism; Personal Autonomy; Pharmaceutical Preparations; Risk; Risk Assessment; Social Control, Formal; United States Food and Drug Administration | 1984 |
Paternalism and the regulation of drugs.
Topics: Amygdalin; Ethical Analysis; Ethical Theory; Ethics; Federal Government; Freedom; Government; Government Regulation; Human Rights; Humans; Jurisprudence; Neoplasms; Paternalism; Patient Advocacy; Patient Rights; Personal Autonomy; Pharmaceutical Preparations; Risk; Risk Assessment; Social Control, Formal; Terminal Care; United States Food and Drug Administration | 1984 |
Governmental regulation of heart transplantation and the right to privacy.
Topics: Abortion, Induced; Amygdalin; Biomedical Technology; Civil Rights; Complementary Therapies; Contraception; Delivery of Health Care; Federal Government; Financing, Government; Freedom; Government; Government Regulation; Health Care Rationing; Heart; Hospitals; Humans; Jurisprudence; Medicaid; Medicare; Organ Transplantation; Privacy; Public Policy; Reference Standards; Resource Allocation; Social Control, Formal; Supreme Court Decisions; United States | 1985 |
Medicine and human rights: emerging substantive standards and procedural protections for medical decision making within the American family.
Topics: Abortion, Induced; Adolescent; Adult; Amygdalin; Bioethical Issues; Bioethics; Civil Rights; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Decision Making; Ethics Committees; Ethics Committees, Clinical; Euthanasia, Passive; Family; Freedom; Humans; Informed Consent; Judicial Role; Jurisprudence; Legal Guardians; Mental Competency; Minors; Parental Consent; Paternalism; Patient Advocacy; Patient Care; Patients; Persistent Vegetative State; Personal Autonomy; Persons with Mental Disabilities; Pharmaceutical Preparations; Physicians; Right to Die; Spouses; Sterilization, Reproductive; Supreme Court Decisions; Third-Party Consent; Tissue and Organ Procurement; Tissue Donors; Treatment Refusal; United States | 1983 |
Laetrile--consumer protection is the bottom line.
Topics: Amygdalin; Freedom; Government Regulation; Humans; Neoplasms; Patient Care; Personal Autonomy; Pharmaceutical Preparations; Politics; Social Control, Formal; Terminally Ill | 1977 |
Freedom of choice in medical treatment: reconsidering the efficacy requirement of the FDCA.
Topics: Amygdalin; Civil Rights; Federal Government; Freedom; Government; Government Regulation; Human Experimentation; Humans; Jurisprudence; Neoplasms; Patient Care; Personal Autonomy; Pharmaceutical Preparations; Privacy; Public Policy; Reference Standards; Social Control, Formal; United States Food and Drug Administration | 1977 |
People v. Privitera: the right to prescribe and use Laetrile.
Topics: Amygdalin; Civil Rights; Federal Government; Freedom; Government; Government Regulation; Humans; Neoplasms; Patient Care; Patients; Personal Autonomy; Pharmaceutical Preparations; Physicians; Public Policy; Social Control, Formal; State Government; United States | 1978 |
The Laetrile controversy: freedom of choice in medicines urged.
Topics: Amygdalin; Attitude; Federal Government; Freedom; Government; Government Regulation; Humans; Neoplasms; Patient Care; Personal Autonomy; Pharmaceutical Preparations; Public Policy; Social Control, Formal; United States Food and Drug Administration | 1977 |
Laetrile: statutory and constitutional limitations on the regulation of ineffective drugs.
Topics: Amygdalin; Civil Rights; Evaluation Studies as Topic; Federal Government; Freedom; Government; Government Regulation; Humans; Judicial Role; Jurisprudence; Legislation, Drug; Neoplasms; Personal Autonomy; Pharmaceutical Preparations; Physician-Patient Relations; Politics; Privacy; Reference Standards; Risk; Risk Assessment; Social Control, Formal; Terminally Ill; United States Food and Drug Administration | 1978 |
Laetrile: individual choice for cancer patients.
Topics: Amygdalin; Civil Rights; Delivery of Health Care; Evaluation Studies as Topic; Federal Government; Freedom; Government; Government Regulation; History; Humans; Jurisprudence; Neoplasms; Personal Autonomy; Pharmaceutical Preparations; Privacy; Risk; Risk Assessment; Social Control, Formal; State Government | 1978 |
People v. Privitera.
Topics: Amygdalin; Civil Rights; Freedom; Government Regulation; Humans; Informed Consent; Jurisprudence; Neoplasms; Patient Care; Patients; Personal Autonomy; Pharmaceutical Preparations; Physicians; Privacy; Social Control, Formal | 1977 |
How would you cope with these ethical dilemmas?
Topics: Amygdalin; Bioethical Issues; Bioethics; Communication; Confidentiality; Freedom; Humans; Personal Autonomy; Pharmaceutical Preparations; Physician-Patient Relations; Physician's Role; Referral and Consultation; Right to Die; Sexually Transmitted Diseases; Social Values; Suicide; Terminally Ill | 1977 |
Laetrile--of choice and effectiveness.
Topics: Amygdalin; Drug Approval; Freedom; Government Regulation; History, 16th Century; History, 19th Century; History, 20th Century; Humans; Legislation, Drug; Neoplasms; Paternalism; Public Policy; United States; United States Food and Drug Administration | 1983 |